ArtVentive Launches U.S. commercialization by Showcasing its EOS™ Device at GEST-2016. May 2016, New York
ArtVentive Medical Group, Inc. commenced the launch of its flagship occlusion device product, the ArtVentive Endoluminal Occlusion System (EOS™) at the Global Embolization Symposium and Technologies (GEST) in New York, NY on May 5-8. The introduction in the United States follows the initial commercialization in the E.U. last year.
Join us at the ArtVentive Booth #28 to learn more about the EOS™ Endoluminal Occlusion System at the GEST 2016 U.S. conference in New York.
Conference Dates: 05/05/16 – 05/08/16.